Pyrolysis Mass Spectrometry A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection Preliminary Work with M. malmoense》.pdf
- 1、本文档共8页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Pyrolysis Mass Spectrometry A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection Preliminary Work with M. malmoense》.pdf
Zbl. Bakt. 285, 291-298 (1996)
© Gustav Fischer Verlag, Jena
Pyrolysis Mass Spectrometry: A Predictor of Clinical Response
to Treatment in Pulmonary Opportunist Mycobacterial
Infection: Preliminary Work with M. malmoense
M. L. HEGINBOTHOM and J. T. MAGEE
Department of Medical Microbiology and Public Health Laboratory, University Hospital
of Wales, Cardiff, UK
Summary
Pyrolysis mass spectrometry (Py-MS) yields data reflecting overall cell composition. The
changes in composition induced by treatment with rifampicin and ethambutol, alone and
in combination, were investigated for a collection of seven strains of Mycobacterium mal-
moense from pulmonary infections. Two strains, both from patients that had responded to
therapy with this combination, showed large changes in composition from control, un-
treated cultures. The difference was particularly marked for the ethambutol treated cultures.
Four strains, all from patients who had failed to respond to therapy with this combination,
showed minimal changes in composition for all treatments. The remaining strain also show-
ed minimal treatment-induced change, but, for this patient, therapy with the combination
had proved successful. Minimum inhibitory concentrations (MICs) were determined radio-
metrically. All strains showed MICs 0.5 !J.glmL for rifampicin (sensitive) and of 8 !J.glmL
for ethambutol (resistant). MIC results did not correlate with clinical response, whereas the
Py-MS results correlated with clinical response for six of the seven isolates. Py-MS may have
a role in predicting effective therapy for this problem group.
Introduction
Opportunist mycobacteria are a recognised cause of pulmonary disease (5, 8, 29,
30, 33, 36, 37), the treatment of which requires a combination of antimycobacterial
agents. The combination of agents combats the emergence of resistant mutants, and
targets distinct portions of the heterogeneous bacterial popul
您可能关注的文档
- Pseudomonas alcaligenes infection and mortality in cultured Chinese sturgeon, Acipenser sinensis》.pdf
- Pseudoparity propensity rules for vibronic perturbations in neutral alternant hydrocarbons》.pdf
- Pseudorapidity distribution of charged hadrons in proton–proton collisions at》.pdf
- Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin》.pdf
- PSF hollow fiber membrane fabricated from PSF–HBPE–PEG400–DMAc dope solutions via reverse thermally induced phase separation (RTIPS) process》.pdf
- PSO based approach for scheduling NPD projects including overlapping process》.pdf
- PSO based bio inspired algorithms for reactive power planning》.pdf
- Psychoeducational Group Counseling for Academic Achievement of Undergraduate Students in Thailand in the Southern Unrest Province》.pdf
- Psychologic Adjustment to Irreversible Vision Loss in Adults A Systematic Review》.pdf
- Psychological and behavioral adjustment in female youths with high or low psychopathic traits》.pdf
文档评论(0)